GALECTIN THERAPEUTICS INC. Operating Lease Right-of-Use Assets
GALECTIN THERAPEUTICS INC. (GALT) had Operating Lease Right-of-Use Assets of $118.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $118.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $6.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $22.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $37.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $118.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $22.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $37.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $52.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $66.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $16.00K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $26.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $35.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $45.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $46.00K 10-K · filed 2025-03-31 | $53.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $62.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $70.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $78.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $86.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $93.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $101.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $108.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $7.00K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $18.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |